Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanoma.
暂无分享，去创建一个
R. Gonzalez | S. O’Day | R. Deck | R. Weber | R. Allen | L. Spitler | S. Cruickshank | J. Good | M. Timmerman | M. Cook | P. Ames | J. Meyer | Madalene Rose | Sharon Trautvetter | S. O'Day | M. Rose